Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EV/EBITDA | ? | -0.09 | 0.32 | -0.20 | -0.53 | 1.22 | -0.42 | |
| Changes by years, y/y, % | -99% | -450% | -163% | +161% | -331% | |||
Black Diamond Therapeutics. EV/EBITDA
Black Diamond Therapeutics. EV/EBITDA, changes, %
Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EV/EBITDA | ? | -0.57 | 11.7 | 2.38 | 5.43 | 0.98 | -0.42 | |
| Changes by years, y/y, % | +80% | -678% | -231% | -382% | -273% | |||
| Changes by quarters, q/q, % | -70% | -2 158% | -80% | +128% | -82% | |||